The postprandial chylomicron triacylglycerol response to dietary fat in healthy male adults is significantly explained by a combination of single nucleotide polymorphisms in genes involved in triacylglycerol metabolism

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 3, 2014, Pages

  Desmarchelier, Charles ^a   Martin, Jean Charles ^a   Planells, Richard ^a   Gastaldi, Marguerite ^a   Nowicki, Marion ^a   Goncalves, Aurélie ^a   Valéro, René ^a   Lairon, Denis ^a   Borel, Patrick ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; CD36 ANTIGEN; CHYLOMICRON; CHYLOMICRON TRIACYLGLYCEROL; INSULIN RECEPTOR SUBSTRATE 1; MELANOCORTIN 4 RECEPTOR; TRANSCRIPTION FACTOR 7 LIKE 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABCA1 GENE; APOA1 GENE; APOA5 GENE; APOB GENE; ARTICLE; BET1 GENE; CD36 GENE; COBLL1 GENE; ELOVL5 GENE; FAT INTAKE; FAT TOLERANCE TEST; FEMALE; FRMD GENE; GENE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; GPAM GENE; HUMAN; HUMAN EXPERIMENT; INSIG2 GENE; IRS1 GENE; LDLR GENE; LIPC GENE; LIPID METABOLISM; LPL GENE; LYPLAL1 GENE; MALE; MC4R GENE; MICROARRAY ANALYSIS; NAT2 GENE; NORMAL HUMAN; PARK2 GENE; POSTPRANDIAL STATE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLC27A5 GENE; TCF7L2 GENE; TRIACYLGLYCEROL BLOOD LEVEL; ZNF664 GENE;

ADULT; CARDIOVASCULAR DISEASES; CHYLOMICRONS; DIETARY FATS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPID METABOLISM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPRANDIAL PERIOD; RISK FACTORS; TRIGLYCERIDES;

EID: 84895811341     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3962     Document Type: Article

References (20)

1. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106:453-458. (Pubitemid 30666377)
2. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B-12B. (Pubitemid 28113939)
3. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 1998;97:1029-1036.
4. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713.
5. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161-169. (Pubitemid 351171403)
6. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309-316. (Pubitemid 47080485)
7. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Non-fasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299-308. (Pubitemid 47080484)
8. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res. 1988;29:469-479.
9. Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr. 2007;98:458-473. (Pubitemid 47272862)
10. Perez-Martinez P, Delgado-Lista J, Perez-Jimenez F, Lopez-Miranda J. Update on genetics of postprandial lipemia. Atheroscler Suppl. 2010;11:39-43.
11. Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F, Ordovas JM. Influence of genetic factors in the modulation of postprandial lipemia. Atheroscler Suppl. 2008;9:49-55.
12. Ryan MF, Grada CO, Morris C, et al. Within-person variation in the postprandial lipemic response of healthy adults. Am J Clin Nutr. 2013;97:261-267.
13. Weiss EP, Fields DA, Mittendorfer B, Haverkort MA, Klein S. Reproducibility of postprandial lipemia tests and validity of an abbreviated 4-hour test. Metabolism. 2008;57:1479-1485.
14. Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002;8:1439-1444. (Pubitemid 36019430)
15. 1H NMR metabonomics can differentiate the early atherogenic effect of dairy products in hyperlipidemic hamsters. Atherosclerosis. 2009;206:127-133.
16. Thabuis C, Destaillats F, Lambert DM, et al. Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice. J Lipid Res. 2011;52:1373-1382.
17. Storey JD. A direct approach to false discovery rates. J R Stat Soc Ser B. 2002;64:479-498.
18. 100-containing lipoproteins in atherogenesis. Curr Opin Lipidol. 2002;13:461-470.
19. Borel P, de Edelenyi FS, Vincent-Baudry S, et al. Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans. Ann Med. 2011;43:47-59.
20. Long N, Gianola D, Rosa GJ, Weigel KA. Dimension reduction and variable selection for genomic selection: application to predicting milk yield in Holsteins. J Anim Breed Genet. 2011;128:247-257.